DK0801948T3 - Oftalmisk sammensætning med forlænget opholdstid i øjet - Google Patents

Oftalmisk sammensætning med forlænget opholdstid i øjet

Info

Publication number
DK0801948T3
DK0801948T3 DK97103736T DK97103736T DK0801948T3 DK 0801948 T3 DK0801948 T3 DK 0801948T3 DK 97103736 T DK97103736 T DK 97103736T DK 97103736 T DK97103736 T DK 97103736T DK 0801948 T3 DK0801948 T3 DK 0801948T3
Authority
DK
Denmark
Prior art keywords
eye
preserving agent
residence time
ophthalmic composition
ammonium salt
Prior art date
Application number
DK97103736T
Other languages
English (en)
Inventor
Guenther Dr Bellmann
Gudrun Dr Claus-Herz
Original Assignee
Mann Gerhard Chem Pharm Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mann Gerhard Chem Pharm Fab filed Critical Mann Gerhard Chem Pharm Fab
Application granted granted Critical
Publication of DK0801948T3 publication Critical patent/DK0801948T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97103736T 1996-04-15 1997-03-06 Oftalmisk sammensætning med forlænget opholdstid i øjet DK0801948T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19614823A DE19614823A1 (de) 1996-04-15 1996-04-15 Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Publications (1)

Publication Number Publication Date
DK0801948T3 true DK0801948T3 (da) 2001-09-10

Family

ID=7791310

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97103736T DK0801948T3 (da) 1996-04-15 1997-03-06 Oftalmisk sammensætning med forlænget opholdstid i øjet

Country Status (16)

Country Link
US (2) US6599944B1 (da)
EP (1) EP0801948B1 (da)
JP (1) JP4582822B2 (da)
CN (1) CN1215988A (da)
AT (1) ATE201820T1 (da)
AU (1) AU714093B2 (da)
BR (1) BR9708669A (da)
CA (1) CA2251982C (da)
DE (2) DE19614823A1 (da)
DK (1) DK0801948T3 (da)
ES (1) ES2159783T3 (da)
GR (1) GR3036498T3 (da)
PL (1) PL187339B1 (da)
PT (1) PT801948E (da)
SI (1) SI0801948T1 (da)
WO (1) WO1997038674A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19614823A1 (de) 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
DE19744113A1 (de) * 1997-10-06 1999-04-15 Mann Gerhard Chem Pharm Fab Dexamethason-Gel
IN185228B (da) * 1999-02-03 2000-12-09 Bakulesh Mafatlal Dr Khamar
DE19918324A1 (de) * 1999-04-22 2000-10-26 Mann Gerhard Chem Pharm Fab Pharmazeutische Zusammensetzung wirksam gegen durch Bakterien, Viren, Pilze, Hefen und Protozoen verursachte Krankheitszustände
DE19938668B4 (de) * 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
DE10132876A1 (de) * 2001-07-06 2003-01-30 Medproject Pharma Entwicklungs Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge
US8545487B2 (en) * 2007-12-05 2013-10-01 Avedro Inc. Eye therapy system
US8366689B2 (en) * 2008-09-30 2013-02-05 Avedro, Inc. Method for making structural changes in corneal fibrils
WO2011050164A1 (en) 2009-10-21 2011-04-28 Avedro, Inc. Eye therapy
US20110237999A1 (en) * 2010-03-19 2011-09-29 Avedro Inc. Systems and methods for applying and monitoring eye therapy
US9044308B2 (en) 2011-05-24 2015-06-02 Avedro, Inc. Systems and methods for reshaping an eye feature
WO2012167260A2 (en) 2011-06-02 2012-12-06 Avedro, Inc. Systems and methods for monitoring time based photo active agent delivery or photo active marker presence
CN102416011A (zh) * 2011-10-10 2012-04-18 艾硕特生物科技(昆明)有限公司 一种广谱、高效的抗菌洗液
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
JP6360039B2 (ja) 2012-05-03 2018-07-18 カラ ファーマシューティカルズ インコーポレイテッド 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
ES3055223T3 (en) 2012-05-03 2026-02-10 Alcon Inc Pharmaceutical nanoparticles showing improved mucosal transport
WO2013059837A2 (en) 2012-07-16 2013-04-25 Avedro, Inc. Systems and methods for corneal cross-linking with pulsed light
WO2014205145A1 (en) 2013-06-18 2014-12-24 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9308165B2 (en) * 2013-08-22 2016-04-12 Therapeutic Vision, Inc. Composition for treating ocular effects of diabetes
KR102416876B1 (ko) 2014-10-27 2022-07-05 아베드로 인코퍼레이티드 눈의 교차-결합 처리를 위한 시스템 및 방법
US10114205B2 (en) 2014-11-13 2018-10-30 Avedro, Inc. Multipass virtually imaged phased array etalon
EP3285704B1 (en) 2015-04-24 2020-11-18 Avedro Inc. Systems for photoactivating a photosensitizer applied to an eye
US10028657B2 (en) 2015-05-22 2018-07-24 Avedro, Inc. Systems and methods for monitoring cross-linking activity for corneal treatments
US11207410B2 (en) 2015-07-21 2021-12-28 Avedro, Inc. Systems and methods for treatments of an eye with a photosensitizer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399834A (en) * 1971-05-12 1975-07-02 Fisons Ltd Pharmaceutical compositions
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
AU499860B2 (en) * 1975-04-24 1979-05-03 Honda Giken Kogyo Kabushiki Kaisha Deflector plate to equalise fuel distribution in induction gas flow
JPS5313588A (en) * 1976-07-23 1978-02-07 Alcon Lab Inc Ophthalmic solution
GB2013084B (en) * 1978-01-25 1982-07-28 Alcon Lab Inc Ophthalmic drug dosage
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
DE3415663A1 (de) * 1984-04-27 1985-10-31 Sandoz-Patent-GmbH, 7850 Lörrach Eine neue ophthalmologische verabreichungsform
US4738851A (en) * 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
FR2679773A1 (fr) * 1991-07-30 1993-02-05 Merck Sharp & Dohme Preparation ophtalmique contenant un agent osmotique acceptable antimicrobien.
AU5599594A (en) * 1992-11-16 1994-06-08 Ciba-Geigy Ag Polyvinyl alcohol/borate ophthalmic drug delivery system
WO1994015597A1 (en) * 1993-01-11 1994-07-21 Allergan, Inc. Ophthalmic compositions comprising benzyllauryldimethylammonium chloride
DE19614823A1 (de) 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Also Published As

Publication number Publication date
US6599944B1 (en) 2003-07-29
ATE201820T1 (de) 2001-06-15
DE59703711D1 (de) 2001-07-12
JP2000508646A (ja) 2000-07-11
PL328656A1 (en) 1999-02-15
CA2251982C (en) 2008-01-29
ES2159783T3 (es) 2001-10-16
DE19614823A1 (de) 1997-10-16
CN1215988A (zh) 1999-05-05
JP4582822B2 (ja) 2010-11-17
PT801948E (pt) 2001-10-31
EP0801948A1 (de) 1997-10-22
BR9708669A (pt) 1999-08-03
EP0801948B1 (de) 2001-06-06
PL187339B1 (pl) 2004-06-30
SI0801948T1 (en) 2001-10-31
US20040071778A1 (en) 2004-04-15
WO1997038674A1 (de) 1997-10-23
CA2251982A1 (en) 1997-10-23
AU714093B2 (en) 1999-12-16
GR3036498T3 (en) 2001-11-30
AU2024697A (en) 1997-11-07

Similar Documents

Publication Publication Date Title
DK0801948T3 (da) Oftalmisk sammensætning med forlænget opholdstid i øjet
DE69715049D1 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
MX9306735A (es) Nuevos agentes antimicrobianos polimericos y su uso en composiones farmaceuticas.
ATE283032T1 (de) Formulierungen und verfahren zur verminderung von hautirritationen
DE69530418D1 (de) Formulierungen und verfahren zur verminderung von hautirritationen
ATE163259T1 (de) Mittel zur regulierung vom hautfettigkeitsgrad
AU2824600A (en) Cosmetics
BR9407910A (pt) Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto
ATE121287T1 (de) Verfahren zur behandlung der alopezie.
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
ATE218868T1 (de) Hustenhemmende, theobromine enthaltende zusammensetzungen
DE69010263D1 (de) Zahnreinigende Zusammensetzungen.
BRPI0417175A (pt) composições, método para produzir essas composições, solução que as compreende e métodos para utilizar as mesmas
TR199903271T2 (en) Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�.
AU2001259801A1 (en) 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
DK1128809T3 (da) Vandige oftalmiske formuleringer omfattende chitosan
AU2360592A (en) Polyacrylic acid based ophthalmic compositions
WO2003070180A3 (en) Compositions and methods for delivery of skin cosmeceuticals
ATE245980T1 (de) Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern
BR0308633A (pt) Composições, métodos para bioestimular as agrìcolas, e, uso das composições
DE60003074D1 (de) Fusidinsäure-derivate
ES2058097T3 (es) Agente antibacterial para su uso en mamiferos y que comprende derivados de cefalosporina como ingrediente activo.
BR9916267A (pt) Amido polibiguanidas e uso das mesmas como agentes antimicrobianos
ES2109937T3 (es) Uso de hexetidina o sus derivados o sales para la preparacion de una composicion farmaceutica para uso oftalmico.
ATE132003T1 (de) Sterilisierende zusammensetzung